FIELD: medicine.
SUBSTANCE: invention concerns peptides representing VIP fragments, as well as compositions containing said peptide for treating fibroid heart and/or an associated conditions.
EFFECT: invention provides a considerable success in the therapy of fibroid heart or the associated condition.
21 cl, 3 ex, 9 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR TREATMENT OF AORTA FIBROSIS | 2010 |
|
RU2536223C2 |
| COMPOSITIONS AND METHODS OF TREATING CARDIOVASCULAR DISEASE | 2005 |
|
RU2387454C2 |
| COMPOSITIONS AND METHODS OF TREATING RENAL DISORDERS | 2009 |
|
RU2519124C2 |
| THERAPEUTIC AGENT FOR THE TREATMENT OF CARDIOMYOPATHY, PREVIOUS MYOCARDIAL INFARCTION AND CHRONIC HEART FAILURE | 2018 |
|
RU2795320C2 |
| SELECTIVE INHIBITORY PEPTIDES Nox-1 AND USE THEREOF | 2014 |
|
RU2699726C2 |
| USE OF PEPTIDE FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2013 |
|
RU2672341C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBODIES TO HUMAN PCSK9 | 2012 |
|
RU2604139C2 |
| APOPTOSIS INHIBITORS AND USE THEREOF | 2011 |
|
RU2582247C2 |
| MODIFIED VASOACTIVE INTESTINAL PEPTIDES | 2010 |
|
RU2589255C2 |
| ANTIBODIES TO GLUCAGON RECEPTOR AND THEREOF APPLICATION | 2009 |
|
RU2562110C2 |
